Month: April 2017

New Study Demonstrates Synergistic Anti-Cancer Effects of Oncolytic Virus Combined with Immune Checkpoint Inhibitor

Oncolytic viruses can selectively kill cancer cells and cancer-promoting cells, either directly by binding and infecting them, or indirectly by eliciting a targeted immune response against them. UPCI investigators have been examining the anti-cancer efficacy of an immune-stimulating vaccinia virus,

Top